Thing is, my suspicion is that it will be considered independently, because its used for a different indication. Hence the accelerated approval pathway in this particular indication for Peds Steroid Refractory Acute GVHD.
@otherperspective posted something very good about this today. Which I will repost here -
-
- There are more pages in this discussion • 718 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
-0.035(2.09%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.68 | $1.63 | $2.526M | 1.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 6632 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 23640 | 26 |
View Market Depth
| Last trade - 11.26am 03/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |